Epistem Holdings Plc (Epistem), the personalised medicine and biotechnology company, announced that it has entered into a collaborative funding agreement with the Global Health Investment Fund I, LLC (GHIF) to support the roll-out of its Genedrive® molecular diagnostic platform as the company's tuberculosis assay enters pivotal field trials in key developing world locations.
Source: Epistem Holdings Plc